Research Article
Correlation between Post-COVID-19, Chemosensitive Function, Blood Group, and Oral Health-Related Quality of Life
Table 3
Chi-square test of association between ABO blood groups and chronic chemosensitive dysfunction in post- COVID-19 patients (fishers exact test).
| | Chemosensitive dysfunction | ABO blood groups | Chi-square | df | value | | A | AB | B | O |
| | Subjective loss of smell | | Anosmia | 2 (25.0%) | 1 (12.5%) | 2 (25.0%) | 3 (37.5%) | 24.362 | 12 | 0.006 | | Severe hyposmia | 3 (21.4%) | 1 (7.1%) | 2 (14.3%) | 8 (57.1%) | | Moderate hyposmia | 13 (46.4%) | 4 (14.3%) | 3 (10.7%) | 8 (28.6%) | | Mild hyposmia | 9 (75.0%) | 0 (0.0%) | 1 (8.3%) | 2 (16.7%) | | Normal | 5 (13.2%) | 2 (5.3%) | 6 (15.8%) | 25 (65.8%) | | Subjective loss of taste | | | | | 13.174 | 12 | 0.300NS | | Ageusia | 3 (21.4%) | 1 (7.1%) | 3 (21.4%) | 7 (50.0%) | | Severe hypogeusia | 5 (33.3%) | 2 (13.3%) | 2 (13.3%) | 6 (40.0%) | | Moderate hypogeusia | 12 (44.4%) | 3 (11.1%) | 3 (11.1%) | 9 (33.3%) | | Mild hypogeusia | 7 (58.3%) | 0 (0.0%) | 1 (8.3%) | 4 (33.3%) | | Normal | 5 (15.6%) | 2 (6.2%) | 5 (15.6%) | 20 (62.5%) | | CCCRC score | | | | | 1.806 | 3 | 0.619 NS | | Good | 18 (31.0%) | 3 (5.2%) | 9(15.5%) | 28(48.3%) | | Poor | 14 (33.3%) | 5 (11.9%) | 5 (11.9%) | 18 (42.9%) | | Dysgeusia | | | | | 0.952 | 3 | 0.839 NS | | No | 29 (33.0%) | 7 (8.0%) | 13 (14.8%) | 39 (44.3%) | | Yes | 3 (25.0%) | 1 (8.3%) | 1 (8.3%) | 7 (58.3%) | | Taste intensity score | | | | | 13.888 | 9 | 0.096 NS | | 1 | 6 (31.6%) | 1 (5.3%) | 3 (15.8%) | 9 (47.4%) | | 2 | 6 (16.2%) | 3 (8.1%) | 4 (10.8%) | 24 (64.9%) | | 3 | 9 (37.5%) | 2 (8.3%) | 4 (16.7%) | 9 (37.5%) | | 4 | 11 (55.0%) | 2 (10.0%) | 3 (15.0%) | 4 (20.0%) |
|
|
NS: not significant ( ) : significant ( ). |
